THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 4,695,000 Value ($000) $4,354 Avg Close — Range —